FOXO | FOXO Technologies Inc. Stock Overview

(Stock Exchange: AMEX)

Day's Range	0.2767 - 0.3400
52 Week Range	0.1300 - 1.3000
Beta	N/A
Implied Volatility	N/A
IV Rank	N/A
Day's Volume	2,039,494
Average Volume	48,739,212
Shares Outstanding	17,476,600
Market Cap	4,910,925
Sector	Healthcare
Industry	Medical - Healthcare Information Services
IPO Date	2022-09-16

Valuation
Profitability
Growth
Health
P/E Ratio	5.62
Forward P/E Ratio	N/A
EPS	0.05
1YR Price Target	N/A
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	4
Country	USA
Website	FOXO

FOXO Technologies Inc., a technology platform company, focuses on commercializing longevity science through products and services that serve the life insurance industry. The company is developing products and services that combine longevity science with life insurance to support the consumer health and wellness engagement, and to simplify the consumer underwriting journey. It offers FOXO Labs, a services platform that integrates saliva-based epigenetic biomarkers into accelerated underwriting protocols to improve the customer underwriting journey; and FOXO Life, an insurance products platform that offers proprietary life insurance products and third-party life insurance carrier products based on bundling longevity science with life insurance. The company was founded in 2019 and is based in Minneapolis, Minnesota.

FOXO's peers: BEAT, HCTI, MPLN, SY, VS, WORX, ZCMD, NUTX, ACON, EUDA, UTRS, MGRX, ETAO, SNCE, AUGX, WGS, BFRG

*Chart delayed

Analyzing fundamentals for FOXO we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is bad and Health is frighteningly weak. For more detailed analysis please see FOXO Fundamentals page.

Watching at FOXO technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, as well as bearish short-term trend. More technicals details can be found on FOXO Technicals page.